Use access key #2 to skip to page content.
$23.66 -1.83 (-7.18%)
10/6/2008 4:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating:
****

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

View All Commentary (BMRN)

Recs

7

Avatar JSIMMS001 (87.67) Submitted: 8/24/06 10:43 AM : Outperform Start Price: $15.70 BMRN Score: 70.20

This Company has already outperformed the S&P this year and is on Pace to do it again next year. With new drugs coming out of the pipeline and an increasing client base. This Company should prove a solid hold for the next few years.

Report this Post Replies: 0 | Reply

Featured Broker Partners